Oric Pharmaceuticals (ORIC)

• Market cap: $1.22B
• 1 day: 1.78%
• 5 days: -5.26%
• 1 month: 16.45%
• 3 months: 13.92%
• 6 months: 158.73%
• Year to date: 52.54%
• 1 year: 38.16%
• 5 years: -41.45%
• 10 years: -51.11%
• Sector: Healthcare
• Industry: Biotechnology

About: ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

Employees: 128